3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
26
Neoplasm Metastasis
7
Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Advanced Solid Tumors
2
Thyroid Neoplasms
1
Recurrence Free Survival
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Histiocytosis
1
Glioma
1
Fallopian Tube Neoplasms
1
Erythema
1
Endometrial Neoplasms
1
Edema
1
Dihydropyrimidine Dehydrogenase Deficiency
1
Colorectal Cancer Metastatic
1
Cholangiocarcinoma
1
Interventions
Temozolomide
100
Radiotherapy
49
Magnetic Resonance Spectroscopy
38
Radiation
28
Specimen Handling
25
pembrolizumab
22
Bevacizumab
22
Lomustine
16
Nivolumab
14
Surgical Procedures, Operative
10
atezolizumab
8
Cyclophosphamide
8
Biopsy
8
abemaciclib
7
Ipilimumab
7
fludarabine
6
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
Aminolevulinic Acid
6
olaparib
5
Metformin
5
Drug Therapy
5
Diet, Ketogenic
5
Dianhydrogalactitol
5
poly ICLC
4
cemiplimab
4
Radiosurgery
4
Photons
4
Leukapheresis
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Panitumumab
×
1 year
×
Clear all
No trials found.